Verrica Pharmaceuticals Inc.
Market Cap
$67.21M
P/E Ratio
-3.76
EPS
$-1.68
Dividend Yield
0.00%
52-Week Range
$3.28 — $9.82
Volume
94.68K
Avg Volume
152.54K
Beta
1.46
P/E (TTM)
-3.76
Forward P/E
—
PEG Ratio
-0.07
P/S (TTM)
1.83
P/B (TTM)
2.63
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
2.52%
ROA (TTM)
-0.38%
ROIC
—
Gross Margin
0.94%
Operating Margin
-0.34%
Net Margin
—
Debt/Equity
0.07
Current Ratio
2.59
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.20%
EPS Growth (5Y)
-0.18%
Sales Growth (3Y)
-0.07%
Sales Growth (5Y)
-0.04%
EPS Est (This Year)
$-1.60
EPS Est (Next Year)
$-1.11
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$2.83
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
9.49M
Float
5.32M
Free Float %
56.03%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2018-06-15
Employees
71
CEO
Jayson Rieger
Index Membership
—
Website
https://www.verrica.com
Verrica Pharmaceuticals Inc. (VRCA) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $67.21M, a P/E ratio of -3.76, VRCA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare VRCA against other stocks using dozens of fundamental and technical filters.
Verrica Pharmaceuticals Inc. (VRCA) has a trailing twelve-month (TTM) P/E ratio of -3.76. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Verrica Pharmaceuticals Inc. (VRCA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Verrica Pharmaceuticals Inc. (VRCA) has a market capitalization of $67.21 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.